miR-9-5p Mediates ABCC1 to Elevate the Sensitivity of Glioma Cells to Temozolomide

miR-9-5p Mediates ABCC1 to Elevate the Sensitivity of Glioma Cells to Temozolomide

Chemotherapy combined with surgery is an important clinical treatment for glioma, but endogenous or acquired temozolomide (TMZ) resistance can lead to poor prognosis. microRNA (miR)-9-5p acts in biological function of glioma, but the drug resistance of miR-9-5p in glioma is under exploration. The st...

Full description

Bibliographic Details
Main Authors: Xiang-Rui Chen, Yan-Guo Zhang, Qiang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
miR-9-5p
BCC1
glioma
temozolomide
MTT assay
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.661653/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.661653/full

Similar Items